XMTR Stock Jumps As Cantor Hikes Price Target To $62

Xometry Inc. stocks have been trading up by 36.33 percent, driven largely by upbeat coverage of its strong growth prospects.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading XMTR

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

Cantor Fitzgerald upgraded Xometry to Overweight from Neutral with a $62 price target, leaning on reshoring, stronger production demand, and past platform investments that expanded market share.
A separate Cantor note reaffirmed its Overweight rating on XMTR and aligned with a FactSet mean price target near $62.62, signaling firm analyst conviction in upside potential.
Xometry plans to release Q1 2026 results and host an earnings call and webcast on 2026/05/07, setting up the next key catalyst for XMTR traders.

Live Update At 12:32:56 EDT: On Thursday, May 07, 2026 Xometry Inc. stock [NASDAQ: XMTR] is trending up by 36.33%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

XMTR has been trading like a momentum freight train. In mid-April 2026, Xometry stock changed hands around the low $40s. By 2026/05/07, XMTR closed at $76.89 after touching $79.98 intraday. That’s roughly an 80%+ run in just a few weeks, driven by growing optimism and, now, a major analyst upgrade.

Zoom in on the intraday tape and you see the story. XMTR gapped up hard at the open, briefly flushed to $69.20, then buyers stepped in and controlled most of the day. The stock held mid‑70s support, with repeated pushes toward the high‑70s. That kind of dip‑buying and higher low structure tells traders there’s real demand behind the move, not just a one‑and‑done headline spike.

More Breaking News

Fundamentally, Xometry is still a growth‑over‑profits story. Revenue is about $686.6M with a strong 39.1% gross margin, but XMTR runs negative EBIT and net margins, plus returns on equity are deep in the red. The balance sheet, however, shows a solid 3.8 current ratio and plenty of liquidity to keep funding growth. For short‑term traders, the focus stays on price action and catalysts. For longer‑term chart readers, XMTR’s rich price‑to‑sales and price‑to‑book ratios underline just how high expectations already are.

Why Traders Are Watching XMTR Right Now

XMTR is front and center on many watchlists because Wall Street just planted a flag. Cantor Fitzgerald moved Xometry from Neutral to Overweight and slapped a $62 price target on the name. More importantly, the firm spelled out why: reshoring tailwinds, more real‑world production use on the platform, and earlier investments that have pushed Xometry deeper into enterprise accounts.

For traders, that matters. This is not a story about one quarter. Cantor is talking about momentum running into 2026 as manufacturers pull supply chains closer to home and look for flexible, on‑demand capacity. XMTR sits right in that lane, matching jobs to a large network of suppliers. When a big shop says the structural trend is at Xometry’s back, momentum traders pay attention.

Another Cantor note reiterated the Overweight call and lined up with a FactSet mean price target around $62.62, which shows the $62 view is not some outlier. The Street, on average, sees XMTR worth roughly that level based on current expectations. With Xometry now trading well above that area after the latest run, traders need to decide: is this a fast‑money overshoot or the market starting to price in an even stronger scenario?

Add one more spark: Xometry will report Q1 2026 results on 2026/05/07. That earnings call is the next major pivot. If XMTR’s revenue growth, margins, and guidance support the bullish reshoring story, the stock can justify holding elevated levels or even extending the trend. If not, any miss or cautious tone can trigger a sharp shakeout in a name that’s already run far, fast.

Conclusion

XMTR is a textbook momentum setup built on a real fundamental narrative. The stock has ripped from the low $40s to the high $70s ahead of its Q1 2026 report, while Cantor Fitzgerald’s Overweight rating and $62 target amplify the bullish tone around Xometry. The firm’s focus on reshoring, deeper enterprise adoption, and a growing base of production jobs gives traders a clear story to track on every earnings slide and every conference call soundbite.

At the same time, the numbers remind everyone what kind of name this is. Xometry’s gross margin is strong, but XMTR is still losing money and trading at high sales and book multiples. When expectations run hot like this, the market stops forgiving mistakes. Any stumble in revenue growth, profitability progress, or demand commentary on 2026/05/07 can flip sentiment fast.

That’s where trading discipline comes in. XMTR offers opportunity for both breakout buyers and reactive shorts, but only for traders who respect risk. As Tim Sykes likes to say, “The market doesn’t care about your opinion, only your discipline.” In the same spirit, As Tim Bohen, lead trainer with StocksToTrade says, “The best trades are the ones you can make without emotion. Plan it, then execute it as if it’s routine.” Treat XMTR as a high‑volatility teaching chart: study the run, map the key levels, plan scenarios around the earnings date, and stay ready to cut losses quickly if the story shifts.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!